• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·KLINIQ.BK
Share

The Klinique Medical Clinic Public Company Limited Stocks

THB 28.75Last Updated 18.09.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

THB 193.00M

THB 28.75
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

The Klinique Medical Clinic Public Company Limited, operating from its headquarters in Bangkok, Thailand, offers a comprehensive suite of services encompassing skin care, cosmetic surgery, and holistic health solutions. Their extensive portfolio of treatments includes a variety of aesthetic and medical procedures. These range from facial rejuvenation and contouring options like facelifts, dermal fillers, and fat-dissolving injections, to body sculpting using "shape up" treatments. The clinic also specializes in advanced dermatological care for issues such as acne and acne scars, alongside general skin enhancement therapies like laser hair removal, targeted skin injections, Mesoface, and meso treatments. Furthermore, they perform specialized surgical interventions for the nose, eyes, and other facial areas.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'che

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of KLINIQ.BK is 29.9 and suggests 3.83% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.09.2026 21:00

Anthropic Has Chosen a Stock Exchange; OpenAI Is Aiming for $1.2 Trillion: Key Takeaways on IPOs by September 20

20.09.2026 15:01

Does having a lot of money make an investor more rational? Yes, but only to a certain extent

19.09.2026 16:01

Small-Cap Highlights: Management Shuffle at Hugo Boss, LSD's Success, Yoox Outlet's Surge

19.09.2026 13:01

AI: To Accelerate or Slow Down? Revolut Takes on Extortionists; Luxury Is Becoming More Affordable

19.09.2026 03:54

Trump signed a law imposing sanctions on Russia. It will affect major oil importers.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026